Evidence map›Paper›PMID 26728506›Full record

ArticleBMC genomics2016

The effects of transfection reagent polyethyleneimine (PEI) and non-targeting control siRNAs on global gene expression in human aortic smooth muscle cells.

Nurazhani A Raof, Deepa Rajamani, Hsun-Chieh Chu, Aniket Gurav, Joel M Johnson, Frank W LoGerfo, Leena Pradhan-Nabzdyk, Manoj Bhasin

Open access · goldAbstract read
In one paragraph

Article in BMC genomics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. NEDD9 targetsScience translational medicine · 2018
    Article
  9. Article
  10. Review
  11. Intraluminal delivery of thrombospondin-2 small interfering RNA inhibits the vascular response to injury in a rat carotid balloon angioplasty model.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2017
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Nurazhani A RaofThe Frank W. LoGerfo Division of Vascular and Endovascular Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Ave, Stoneman 8 M-10E, Boston, 02215, MA, USA. nurazhani@gmail.com.
Deepa RajamaniDivision of Interdisciplinary Medicine and Biotechnology, Genomics and Proteomics Center, Beth Israel Deaconess Medical Center, Harvard Medical School, 99 Brookline Avenue, Boston, MA, 02215, USA. drajaman@bidmc.harvard.edu.
Hsun-Chieh ChuThe Frank W. LoGerfo Division of Vascular and Endovascular Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Ave, Stoneman 8 M-10E, Boston, 02215, MA, USA. Hsunchien@gmail.com.
Aniket GuravThe Frank W. LoGerfo Division of Vascular and Endovascular Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Ave, Stoneman 8 M-10E, Boston, 02215, MA, USA. aniket.gurav@gmail.com.
Joel M JohnsonThe Frank W. LoGerfo Division of Vascular and Endovascular Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Ave, Stoneman 8 M-10E, Boston, 02215, MA, USA. jjohns18@bidmc.harvard.edu.
Frank W LoGerfoThe Frank W. LoGerfo Division of Vascular and Endovascular Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Ave, Stoneman 8 M-10E, Boston, 02215, MA, USA. flogerfo@bidmc.harvard.edu.
Leena Pradhan-NabzdykThe Frank W. LoGerfo Division of Vascular and Endovascular Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Ave, Stoneman 8 M-10E, Boston, 02215, MA, USA. lpradhan@bidmc.harvard.edu.
Manoj BhasinDivision of Interdisciplinary Medicine and Biotechnology, Genomics and Proteomics Center, Beth Israel Deaconess Medical Center, Harvard Medical School, 99 Brookline Avenue, Boston, MA, 02215, USA. mbhasin@bidmc.harvard.edu.
Beth Israel Deaconess Medical Center · USHarvard University · US

Funding

HARVARD-LONGWOOD RESEARCH TRAINING IN VASCULAR SURGERYT32HL007734 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI FERRAN, CHRISTIANE, LOGERFO, FRANK W · 1993 to 2023
$10.5M
MECHANISMS OF PROSTHETIC ARTERIAL GRAFT FAILURER01HL021796 · NHLBI · NEW ENGLAND DEACONESS HOSPITAL · PI FERRAN, CHRISTIANE, LOGERFO, FRANK W · 1987 to 2020
$9.0M
Genetic Engineering of Vein Bypass Grafts in Vascular and Cardiovascular SurgeryR01HL086741 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI BHASIN, MANOJ, FERRAN, CHRISTIANE · 2007 to 2022
$7.4M
NHLBI NIH HHS 5R01HL021796NHLBI NIH HHS 5R01HL086741NHLBI NIH HHS 5T32HL007734NHLBI NIH HHS R01 HL021796NHLBI NIH HHS R01 HL086741NHLBI NIH HHS T32 HL007734
6 · The paper itself

Abstract

backgroundRNA interference (RNAi) is a powerful platform utilized to target transcription of specific genes and downregulate the protein product. To achieve effective silencing, RNAi is usually applied to cells or tissue with a transfection reagent to enhance entry into cells. A commonly used control is the same transfection reagent plus a "noncoding RNAi". However, this does not control for the genomic response to the transfection reagent alone or in combination with the noncoding RNAi. These control effects while not directly targeting the gene in question may influence expression of other genes that in turn alter expression of the target. The current study was prompted by our work focused on prevention of vascular bypass graft failure and our experience with gene silencing in human aortic smooth muscle cells (HAoSMCs) where we suspected that off target effects through this mechanism might be substantial. We have used Next Generation Sequencing (NGS) technology and bioinformatics analysis to examine the genomic response of HAoSMCs to the transfection reagent alone (polyethyleneimine (PEI)) or in combination with commercially obtained control small interfering RNA (siRNAs) (Dharmacon and Invitrogen).

resultsCompared to untreated cells, global gene expression of HAoSMcs after transfection either with PEI or in combination with control siRNAs displayed significant alterations in gene transcriptome after 24 h. HAoSMCs transfected by PEI alone revealed alterations of 213 genes mainly involved in inflammatory and immune responses. HAoSMCs transfected by PEI complexed with siRNA from either Dharmacon or Invitrogen showed substantial gene variation of 113 and 85 genes respectively. Transfection of cells with only PEI or with PEI and control siRNAs resulted in identification of 20 set of overlapping altered genes. Further, systems biology analysis revealed key master regulators in cells transfected with control siRNAs including the cytokine, Interleukin (IL)-1, transcription factor GATA Binding Protein (GATA)-4 and the methylation enzyme, Enhancer of zeste homolog 2 (EZH-2) a cytokine with an apical role in initiating the inflammatory response.

conclusionsSignificant off-target effects in HAoSMCs transfected with PEI alone or in combination with control siRNAs may lead to misleading conclusions concerning the effectiveness of a targeted siRNA strategy. The lack of structural information about transfection reagents and "non coding" siRNA is a hindrance in the development of siRNA based therapeutics.

Indexed as

Computational BiologyAortaEnhancer of Zeste Homolog 2 ProteinGATA4 Transcription FactorGene Expression RegulationGene SilencingHigh-Throughput Nucleotide SequencingHumansInterleukin-1Muscle, Smooth, VascularPolycomb Repressive Complex 2PolyethyleneimineRNA, Small InterferingTransfectionEnhancer of Zeste Homolog 2 ProteinEZH2 protein, humanGATA4 Transcription FactorInterleukin-1Polycomb Repressive Complex 2PolyethyleneimineRNA, Small Interfering

Identifiers

PMID26728506
PMCPMC4700750
OpenAlexW2231560277

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.